GSK Aktie

45,80 EUR +1,60 EUR +3,62 %

21:17:28

STU

53,04 USD +1,84 USD +3,59 %

21:29:56

BTT

GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.89,00 Mrd. EUR

KGV13,19Div. Rendite3,56%

WKNA3DMHS

ISINUS37733W2044

SymbolGSK

GSK Aktien News

Sortieren:Datum Meistgelesen

22.09.25ZacksHere's Why GSK (GSK) is a Strong Growth Stock

17.09.25ZacksGSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years

17.09.25BenzingaGSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Years

17.09.25BBCGSK pledges $30bn US investment as UK's pharma woes deepen

16.09.25ZacksWill GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?

11.09.25BenzingaRecent Report Shows That Rep. Robert Aderholt Sold Up to $15K Worth of GSK Stock

03.09.25BenzingaWhy Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

03.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

02.09.25ZacksGSK Adds Around $5B in a Month: Here's How to Play the Stock

27.08.25BenzingaPrice Over Earnings Overview: GSK

27.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

22.08.25ZacksBMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?

22.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

16.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

08.08.25RSSBioNTech Reaches Agreement to Receive a Non-exclusive License for mRNA-based COVID-19 and/or Influenza Products and Resolve Patent Litigation with CureVac and GSK

31.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

30.07.25ZacksGSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise

30.07.25BenzingaGSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

30.07.25ZacksGSK (GSK) Q2 Earnings and Revenues Beat Estimates

28.07.25BenzingaAfter Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact

28.07.25PR NewswireHengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

27.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK

24.07.25Financial TimesGSK blood cancer drug reapproved by EU regulator

23.07.25ZacksGSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth

18.07.25Financial TimesGSK blood cancer drug fails to win backing of key US regulatory panel

15.07.25BenzingaGSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults

14.07.25ZacksFDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults

02.07.25BenzingaPrice Over Earnings Overview: GSK

27.06.25BenzingaGSK Rebranded Flovent Asthma Inahler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses

23.06.25ZacksGSK (GSK) is a Top-Ranked Value Stock: Should You Buy?

18.06.25ZacksGSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?

17.06.25ZacksHere's Why GSK (GSK) is a Strong Momentum Stock

06.06.25ZacksHere's Why GSK (GSK) is a Strong Value Stock

02.06.25PR NewswireTheravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

07.04.25PR NewswireGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm

31.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK

28.03.25PR NewswireGSK Deadline: GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit

27.03.25PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK

26.03.25PR NewswireViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

GSK News

GSK News: auf dieser Seite finden Sie alle GSK News und Nachrichten zur GSK Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch GSK News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um GSK News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.